This course will study the progression from basic science to the development and application of new therapeutics, with a focus on cancer therapy. The course will present two case studies, one a biologic protein therapeutic and the other a small-molecule drug. For each case study, we will review (1) the basic biology behind a cancer-associated signaling pathway, (2) the rationale and strategy for developing inhibitors of the pathway, and (3) the application of these inhibitors for human therapy. Students will participate in journal-club style reviews and will primarily be graded on a written research proposal.

Coordinators: Dr. Peter Dirks
Dates: October 30 - December 7,  2017 (Exact time & dates TBA. Contact coordinator for details)
Time: TBA
Place: TBA
Enrollment: Class size is limited to 15 students

Please submit your course request by August 15, 2017.

Name *
Degree *
Will you be reclassifying/qualifying in the fall? *
With the exception of Biochemistry students, students from other departments must be registered in MMG1012H in order to take topics through the Department of Molecular Genetics. Biochemistry students should confirm with their Graduate Office to ensure our topics can count towards their module courses.
Students should choose multiple topics in order to ensure that they are able to register for topics this Fall. Indicate the priority of this course in relation to your other choices.